EVE (NYSE:EVEX – Get Free Report)‘s stock had its “overweight” rating restated by research analysts at Cantor Fitzgerald in a research note issued to investors on Monday, Benzinga reports. They currently have a $5.00 target price on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 66.11% from the stock’s previous close.
A number of other equities analysts have also recently issued reports on EVEX. Canaccord Genuity Group lowered their target price on EVE from $9.00 to $8.50 and set a “buy” rating for the company in a report on Tuesday, July 2nd. HC Wainwright initiated coverage on EVE in a report on Tuesday, September 3rd. They set a “buy” rating and a $6.00 price target on the stock.
Check Out Our Latest Analysis on EVEX
EVE Stock Performance
EVE (NYSE:EVEX – Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported ($0.13) EPS for the quarter, hitting analysts’ consensus estimates of ($0.13). As a group, research analysts predict that EVE will post -0.49 EPS for the current fiscal year.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in EVE stock. Blair William & Co. IL purchased a new position in shares of Eve Holding, Inc. (NYSE:EVEX – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 47,017 shares of the company’s stock, valued at approximately $190,000. Institutional investors and hedge funds own 1.27% of the company’s stock.
About EVE
Eve Holding, Inc, together with its subsidiaries, develops urban air mobility solutions. It is involved in the design and production of electrical vertical take-off and landing vehicles (eVTOLs); provision of eVTOL service and support capabilities, including material services, maintenance, technical support, training, ground handling, and data services; and development of urban air traffic management systems.
Further Reading
- Five stocks we like better than EVE
- 3 Warren Buffett Stocks to Buy Now
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Stock Sentiment Analysis: How it Works
- 2 Energy Stocks Fueling the AI Datacenter Boom
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for EVE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EVE and related companies with MarketBeat.com's FREE daily email newsletter.